chevron_leftBack
As of 24 April 2025, Cambridge Cognition Holdings Plc has a market cap of $19.94M USD, ranking #29865 globally and #669 in the United Kingdom. It ranks #2989 in the Healthcare sector, and #142 in the Health Information Services industry.
Key Stats
Market Cap
$19.94MUSD
14.99M GBP
Enterprise Value
$18.5MUSD
13.91M GBP
Revenue (TTM)
$17.4MUSD
13.08M GBP
EBITDA (TTM)
$779.42KUSD
586.0K GBP
Net Income (TTM)
-$1.75MUSD
-1.32M GBP
EBITDA Margin
4.5%
Profit Margin
-10%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Health Information Services
CEO
Matthew Stork
open_in_new
Employees
119
Founded
2012
Website
cambridgecognition.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 1.4% | -10% | -14% | 29% | -31% |
Upcoming Earnings
Earnings Date
Fri, May 2
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
COG
Cambridge Cognition Holdings PLC
ISIN: GB00B8DV9647
Shares Out.:
Shares Outstanding:
41.865M1
Shares Float:
31.146M2
|
36 GBX |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Cambridge Cognition Holdings Plc
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval. It also offers eCOA, a data management tool for clinical scales which supports questionnaires and issue resolutions; and provides cognitive kit for detecting fluctuations in brain health. In addition, the company provides voice analysis tools for monitoring neurological and psychiatric disorders; eConsent, a patient consent solution; and Clinpal, an application for managing patients workflows. Further, it offers AQUA, a speech analysis platform for clinical scales. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.
